261 related articles for article (PubMed ID: 31470608)
1. Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview.
Argentiero A; Solimando AG; Brunetti O; Calabrese A; Pantano F; Iuliani M; Santini D; Silvestris N; Vacca A
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31470608
[TBL] [Abstract][Full Text] [Related]
2. Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases.
Takagi T; Katagiri H; Kim Y; Suehara Y; Kubota D; Akaike K; Ishii M; Mukaihara K; Okubo T; Murata H; Takahashi M; Kaneko K; Saito T
PLoS One; 2015; 10(6):e0129428. PubMed ID: 26115010
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
5. Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice.
Li BT; Wong MH; Pavlakis N
J Clin Med; 2014 Jan; 3(1):1-24. PubMed ID: 26237249
[TBL] [Abstract][Full Text] [Related]
6. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
[TBL] [Abstract][Full Text] [Related]
7. Effect of changing data collection parameters on statistical motor unit number estimates.
Henderson RD; McClelland R; Daube JR
Muscle Nerve; 2003 Mar; 27(3):320-31. PubMed ID: 12635119
[TBL] [Abstract][Full Text] [Related]
8. Physiological characteristics of motor units in the brachioradialis muscle across fatiguing low-level isometric contractions.
Calder KM; Stashuk DW; McLean L
J Electromyogr Kinesiol; 2008 Feb; 18(1):2-15. PubMed ID: 17113787
[TBL] [Abstract][Full Text] [Related]
9. Decrement in surface-recorded motor unit potentials in amyotrophic lateral sclerosis.
Henderson RD; Daube JR
Neurology; 2004 Nov; 63(9):1670-4. PubMed ID: 15534253
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
11. A systematic overview of radiation therapy effects in skeletal metastases.
Falkmer U; Järhult J; Wersäll P; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):620-33. PubMed ID: 14596519
[TBL] [Abstract][Full Text] [Related]
12. The changing landscape of the medical management of skeletal metastases in nonsmall cell lung cancer.
Kosteva J; Langer C
Curr Opin Oncol; 2008 Mar; 20(2):155-61. PubMed ID: 18300765
[TBL] [Abstract][Full Text] [Related]
13. Management of bone metastases in cancer: a review.
Selvaggi G; Scagliotti GV
Crit Rev Oncol Hematol; 2005 Dec; 56(3):365-78. PubMed ID: 15978828
[TBL] [Abstract][Full Text] [Related]
14. Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases.
Costa L; Lipton A; Coleman RE
Support Cancer Ther; 2006 Apr; 3(3):143-53. PubMed ID: 18632488
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates in prostate carcinoma.
Adami S
Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
[TBL] [Abstract][Full Text] [Related]
17. [Bone Metastases - Pathophysiology, Diagnostic Testing and Therapy (Part 1)].
Koob S; Kehrer M; Strauss A; Janzen V; Wirtz DC; Schmolders J
Z Orthop Unfall; 2017 Dec; 155(6):716-726. PubMed ID: 28934820
[TBL] [Abstract][Full Text] [Related]
18. Skeletal complications in cancer patients with bone metastases.
Tsuzuki S; Park SH; Eber MR; Peters CM; Shiozawa Y
Int J Urol; 2016 Oct; 23(10):825-832. PubMed ID: 27488133
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
